Novartis' SMA Gene Therapy Treatment Approved by FDA, Priced at $2.125 Million
The price of the one-and-done gene therapy treatment is about half of what was initially projected by Novartis.
The price of the one-and-done gene therapy treatment is about half of what was initially projected by Novartis.